Literature DB >> 35178168

Biaryl Compounds as Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia (AML).

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2022        PMID: 35178168      PMCID: PMC8842110          DOI: 10.1021/acsmedchemlett.2c00017

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  5 in total

Review 1.  Mitochondrial Metabolism as a Target for Cancer Therapy.

Authors:  Karthik Vasan; Marie Werner; Navdeep S Chandel
Journal:  Cell Metab       Date:  2020-07-14       Impact factor: 27.287

Review 2.  Dihydroorotate dehydrogenase in oxidative phosphorylation and cancer.

Authors:  Stepana Boukalova; Sona Hubackova; Mirko Milosevic; Zuzana Ezrova; Jiri Neuzil; Jakub Rohlena
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-03-06       Impact factor: 5.187

Review 3.  Metabolic traits ruling the specificity of the immune response in different cancer types.

Authors:  Nina C Flerin; Federica Cappellesso; Samantha Pretto; Massimiliano Mazzone
Journal:  Curr Opin Biotechnol       Date:  2020-11-25       Impact factor: 9.740

Review 4.  DHODH and cancer: promising prospects to be explored.

Authors:  Yue Zhou; Lei Tao; Xia Zhou; Zeping Zuo; Jin Gong; Xiaocong Liu; Yang Zhou; Chunqi Liu; Na Sang; Huan Liu; Jiao Zou; Kun Gou; Xiaowei Yang; Yinglan Zhao
Journal:  Cancer Metab       Date:  2021-05-10

Review 5.  Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine.

Authors:  Wanyan Wang; Jiayan Cui; Hui Ma; Weiqiang Lu; Jin Huang
Journal:  Front Oncol       Date:  2021-05-28       Impact factor: 6.244

  5 in total
  1 in total

1.  Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl Moiety.

Authors:  Stefano Sainas; Marta Giorgis; Paola Circosta; Giulio Poli; Marta Alberti; Alice Passoni; Valentina Gaidano; Agnese C Pippione; Nicoletta Vitale; Davide Bonanni; Barbara Rolando; Alessandro Cignetti; Cristina Ramondetti; Alessia Lanno; Davide M Ferraris; Barbara Canepa; Barbara Buccinnà; Marco Piccinini; Menico Rizzi; Giuseppe Saglio; Salam Al-Karadaghi; Donatella Boschi; Riccardo Miggiano; Tiziano Tuccinardi; Marco L Lolli
Journal:  J Med Chem       Date:  2022-09-26       Impact factor: 8.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.